The Impact of the COVID-19 Pandemic on Cancer Patients
- PMID: 32304435
- PMCID: PMC7188063
- DOI: 10.1097/COC.0000000000000712
The Impact of the COVID-19 Pandemic on Cancer Patients
Abstract
In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the treatment) increases their risk of infection compared with the general population. This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- International Pharmaceutical Federation. Coronavirus SARS-CoV-2 outbreak: information and guidelines for pharmacists and the pharmacy workforce. Febuary 12, 2020.
-
- Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioSci Trends. 2020;14:72–73. - PubMed
-
- Zhang H, Huang Y, Xie C. The treatment and outcome of a lung cancer patient infected with SARS-CoV-2. J Thorac Oncol. 2020. Available at: https://www.jto.org/article/S1556-0864(20)30191-X/fulltext. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous